Streetbeat News

Revenues

TTWO

Take-Two Interactive (NASDAQ:TTWO) has received 11 analyst ratings in the past three months, with a shift towards more bullish perspectives. The average 12-month price target has increased by 8.8% to $172.09, with a range from $155.00 to $200.00. Analysts from firms like BMO Capital, Wolfe Research, and Deutsche Bank have provided various ratings and price target adjustments, reflecting changes in market conditions and company performance. Take-Two, known for franchises like 'Grand Theft Auto', faces challenges with a revenue decline of -6.77% and a net margin of -41.84%, but has a strong ROE of -6.26% and ROA of -3.54%, with a low debt-to-equity ratio of 0.42.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 2:00 pm

AZPN

Aspen Technology (NASDAQ:AZPN) has received mixed analyst ratings over the past three months, with 4 analysts offering their evaluations. The recent updates show a shift towards a more positive outlook, with the average 12-month price target increasing to $197.75, up from $187.00. Analysts from Piper Sandler and Baird have raised their price targets, while Loop Capital has announced a 'Buy' rating. Aspen Technology, a global leader in asset optimization software, was partially acquired by Emerson Electric in 2021. The company's financial performance shows challenges in revenue growth, net margin, ROE, and ROA, but a low debt-to-equity ratio suggests prudent financial management.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 2:00 pm

TRIP

Analyst ratings for TripAdvisor (NASDAQ:TRIP) show mixed sentiments with an average 12-month price target of $22.5, up from $19.67. Ratings range from 'Buy' to 'Underweight', reflecting diverse opinions on the company's performance. TripAdvisor's financials indicate strong growth and profitability, with a revenue increase of 16.12% and a net margin of 5.07%. The company's market capitalization is below industry benchmarks, but it has a healthy debt-to-equity ratio of 1.11.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 2:00 pm

SPY

The USA Redbook year-over-year data shows a 5.9% increase compared to the prior figure of 5.6%, indicating a rise in consumer spending.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:55 pm

TLRY

Tilray Brands, Inc. reported a 34% YoY revenue increase in Q2 fiscal 2024, reaching $194 million. The growth was driven by a 35% increase in cannabis net revenue, a 117% increase in beverage alcohol net revenue, and a rise in distribution net revenue. Gross profit rose 11% to $47 million, and adjusted EBITDA was positive at $10.1 million. The company reduced its net loss and continued to expand its business, including medical cannabis in Europe and the craft beverage-alcohol market in the U.S. Shares of Tilray traded 5.56% higher at $2.47 in pre-market.

Portfolio Pulse from Jelena Martinovic

January 09, 2024 | 1:54 pm

NEOG

Neogen Corporation's stock is trading lower following the announcement of disappointing Q2 financial results and a reduction in its sales guidance for FY24, which fell below analyst expectations.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:52 pm

LEXX

Lexaria Bioscience Corp. (NASDAQ:LEXX) has been featured in an editorial by NetworkNewsWire, highlighting the potential of its DehydraTECH(TM) drug-delivery platform to enhance the delivery and efficacy of GLP-1 agonists. These agonists are already used for treating type 2 diabetes and weight loss, and are being researched for additional applications including Alzheimer's, Parkinson's, drug addiction, heart disease, and chronic kidney disease.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:47 pm

IINN

IINNW

Inspira Technologies OXY B.H.N Ltd. (Inspira) announced plans to launch a single-use disposable blood oxygenation kit for its INSPIRA ART device series, targeting a new disposable perfusion market. The kit, expected to be submitted for FDA authorization in 2025, aims to reduce hospital costs and is designed to be compatible with various life support machines. The company's CEO highlighted the potential market expansion and revenue streams, as well as the anticipated FDA clearance of their INSPIRA ART100 device in the first half of 2024.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:42 pm

MSM

MSC Industrial Direct Co Inc (NYSE:MSM) shares dropped after reporting Q1 FY24 results with revenue and adjusted EPS below analyst estimates. Revenue decreased by 0.4% Y/Y to $954.0 million, and adjusted EPS was $1.25, missing the consensus of $1.31. The company also saw a decline in adjusted operating income and a compression in operating margin. Despite the slower start, the company reiterated its FY24 outlook and the CEO expressed optimism about future growth and margin expansion. MSM shares fell 6.40% in premarket trading.

Portfolio Pulse from Lekha Gupta

January 09, 2024 | 1:41 pm

NVRO

Nevro Corp. has announced preliminary revenue for FY23 of $425 million, surpassing the estimated $418.33 million.

Portfolio Pulse from Benzinga Newsdesk

January 09, 2024 | 1:40 pm